Skip to content
FairScopeScope

TikTok Influencers Fueling Unofficial Trade for Unlicensed Slimming Medication

An underground economy for unapproved slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Experimental Drug Gaining Traction Online

The experimental drug, which is still in research studies, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Separately, a flourishing market exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of next-day British shipping. Vendors promote the drug there before directing buyers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies indicate it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, doctors and chemists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in users injecting products of unknown origin.

Some professionals said the demand for the experimental drug could be linked to the increasing cost of approved slimming treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unapproved drug that cannot be marketed or distributed for human use under the British medical regulations.

Some influencers try to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer laws, risking penalties, legal action or imprisonment.

Platform Reaction and Content Elimination

Based on the social media company, the platform has removed problematic content and banned associated hashtags and search suggestions. The company said it was dedicated to keeping the platform safe and allocating resources in enhancing enforcement strategies.

Online Trading Operations

Investigations also found groups with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” instantly brings up channels with numerous of members, populated with photos of slimming results, glowing testimonials and detailed instructions for mixing or injecting at home.

Within moments of joining one community, a vendor posted WhatsApp details, where most purchases occur. The seller sent an instruction manual and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another provided a photo of a alleged testing documentation. None asked about body mass, health issues or past usage.

Item Details and Pricing

Within these communities, messages show black plastic parcels with Royal Mail stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can select between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually priced at 160 pounds for 20 milligrams. When asked how much time a injector should be used, sellers give conflicting responses varying between a several days to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for Telegram stated it actively moderated dangerous material on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Although the science behind this drug is valid, these digital versions may not contain what they claim,” said a pharmacy expert, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service connected the increase in demand to recent cost increases for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are using online platforms. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were made in was sterile,” she explained.

Her staff has already seen individuals harmed by personal administration from unconfirmed sources. “We understand the frustration, but buying from Telegram or communication platforms is gambling with your well-being,” stated the doctor. “These substances could be impure or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in phase 3 research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may expose users to possibly serious medical dangers”.

About the author

Rebecca Barnes

Liam is a tech journalist with a passion for sustainability and ethical consumerism.

FairScopeScope

Type to search articles.